Lunai Bioworks (LNAI) Other Operating Expenses (2013 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Other Operating Expenses of -$1.4 million in Q1 2026, up 19.64% quarter-over-quarter from -$1.8 million in Q4 2025, and up 66.36% on a YoY basis from -$847695.0 in Q1 2025.
Lunai Bioworks (LNAI) Other Operating Expenses (2013 - 2026) Analysis & Trends
Lunai Bioworks' Other Operating Expenses history runs 14 years deep, the most recent figure standing at -$1.4 million for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 66.36% year-over-year to -$1.4 million; the TTM figure through Mar 2026 stood at $114.1 million (up 1155.3% YoY), while the FY2025 annual figure was $152.5 million, up 282.54% from the prior year.
- Other Operating Expenses was -$1.4 million for Q1 2026 at Lunai Bioworks, up from -$1.8 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $118.8 million in Q2 2025 to a low of -$49.9 million in Q2 2024.
- Historically, Other Operating Expenses has averaged $14.4 million across 5 years, with a median of $1506.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Other Operating Expenses slumped 884787.21% in 2023, then surged 2696848.04% in 2024.
- A 5-year view of Other Operating Expenses shows it stood at $1506.0 in 2022, then soared by 296.02% to $5964.0 in 2023, then slumped by 72551.61% to -$4.3 million in 2024, then jumped by 59.39% to -$1.8 million in 2025, then rose by 19.64% to -$1.4 million in 2026.
- The last three Other Operating Expenses figures came in at -$1.4 million (Q1 2026), -$1.8 million (Q4 2025), and -$1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.41 Mn |
| Dec 31, 2025 | -1.75 Mn |
| Sep 30, 2025 | -1.54 Mn |
| Jun 30, 2025 | 118.84 Mn |
| Mar 31, 2025 | -4.19 Mn |
| Dec 31, 2024 | -4.32 Mn |
| Sep 30, 2024 | 47.65 Mn |
| Jun 30, 2024 | -49.95 Mn |
| Mar 31, 2024 | 42.61 Mn |
| Dec 31, 2023 | 5,964.00 |
| Sep 30, 2023 | -13.15 Mn |
| Jun 30, 2023 | 18.96 Mn |
| Mar 31, 2023 | 1,580.00 |
| Dec 31, 2022 | 1,506.00 |
| Sep 30, 2022 | 1,486.00 |
| Jun 30, 2022 | 93.26 Mn |
| Mar 31, 2022 | 3,730.00 |
| Dec 31, 2021 | -189,322.00 |
| Sep 30, 2021 | -45,265.00 |
| Jun 30, 2021 | 4,017.00 |